SCHRODER INVESTMENT MANAGEMENT GROUP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 31 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,970,840
+1.8%
3,000,0000.0%0.00%
-20.0%
Q4 2022$2,919,390
+0.6%
3,000,0000.0%0.01%0.0%
Q3 2022$2,903,000
+1.0%
3,000,0000.0%0.01%
+25.0%
Q2 2022$2,873,000
-1.6%
3,000,0000.0%0.00%0.0%
Q1 2022$2,921,0003,000,0000.00%
Other shareholders

There were no reported owners of LIGAND PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of LIGAND PHARMACEUTICALS INC shareholders